Status:
RECRUITING
Efficacy of Combined Fractional Er:Glass and Thulium Lasers Versus Microneedling for Atrophic Acne Scars
Lead Sponsor:
University of Nove de Julho
Conditions:
Acne Scars
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
The purpose of this study is to compare two treatments for acne scars on the face. The study will test whether fractional lasers (Erbium:Glass and Thulium) lead to better improvement in acne scars tha...
Detailed Description
Acne scars are common and can have a lasting impact on self-esteem, social relationships, and quality of life. Several treatment options exist, but many patients continue to seek better results. Micro...
Eligibility Criteria
Inclusion
- Fitzpatrick skin phototypes I to VI
- Presence of atrophic acne scars on the face
Exclusion
- Decompensated systemic diseases
- Any active infection (e.g., viral such as herpes, bacterial, or fungal)
- Pregnant or breastfeeding women
- Presence of hypertrophic or keloid scars
- Current use of anticoagulant or antiplatelet medications
- History of hemophilia or coagulation disorders
- Current use of anti-inflammatory drugs or corticosteroids
- Use of retinoids, including isotretinoin, within the past 6 months
- Exposure to sunlight within the past 15 days
- Undergoing any aesthetic facial treatment or having undergone scar treatments in the facial region within 180 days prior to study initiation
- Presence of active acne (occasional isolated lesions will not be considered exclusion criteria)
Key Trial Info
Start Date :
October 16 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT07151599
Start Date
October 16 2025
End Date
July 1 2026
Last Update
November 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Espaço Conceito Medical San
São Paulo, Brazil